Topiramate Tablet, Film Coated
Product Images NDC 80425-0488

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 80425-0488). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0ed6c856 4d95 4aeb B925 15346555a2ab 565 2)

FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)
Chemical structure diagram of the active ingredient topiramate. The illustration shows molecular connections and functional groups characteristic of topiramate's chemical composition.*
FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)
A line graph showing cumulative rates for time to first seizure over 500 days, comparing Topiramate 50 mg/day and 400 mg/day doses. The x-axis represents time in days, and the y-axis shows cumulative rates for time to first seizure. The graph includes a p-value of 0.0002 indicating statistical comparison.*
FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)
A bar chart comparing the change from baseline to double-blind phase in average monthly migraine period rates for placebo and topiramate dosed at 50 mg/day, 100 mg/day, and 200 mg/day across two studies. The chart shows a greater reduction in migraine rates with increasing topiramate doses compared to placebo, with statistically significant differences indicated for the 100 mg/day and 200 mg/day doses.*
FDA Label Image

Topiramate 100mg #30 (Topiramate 80425 0488 01)

Topiramate 100mg #30 (Topiramate 80425 0488 01)
Label for Topiramate 100 mg oral film-coated tablets by Advanced Rx of Tennessee, LLC. The label includes NDC 80425-0488-01, lot number placeholder, and expiration date 5/31/2026. It warns to store at 20°-25°C and notes the product is Rx only. It references comparison to Topamax and includes barcode and manufacturer information from Unichem Pharmac.*
FDA Label Image

Topiramate 100mg #60 (Topiramate 80425 0488 02)

Topiramate 100mg #60 (Topiramate 80425 0488 02)
Topiramate 100 mg tablet packaging label from Advanced Rx of Tennessee, LLC, Nashville, TN. The label states the product is sized for 60 tablets and notes comparison to Topamax. Storage instructions indicate a temperature range of 20-25°C (68-77°F). The label includes an NDC number 80425-0488-02, lot number, and expiration date 5/31/2026 along with a barcode and dispensing restriction 'Rx Only.'*
FDA Label Image

Topiramate 100mg #90 (Topiramate 80425 0488 03)

Topiramate 100mg #90 (Topiramate 80425 0488 03)
Label for topiramate 100 mg film-coated tablets by Advanced Rx of Tennessee, LLC, with NDC 80425-0488. The label includes storage instructions, lot number, expiration date of 5/31/2026, and states 'Rx Only'. It references comparable product Topamax and includes a barcode and unique serial number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.